Consensus Guidance for Genetic Counseling in GBA1 Variants: A Focus on Parkinson’s Disease

Output Details

Published September 10, 2024

Glucocerebrosidase (*GBA1*) variants constitute numerically the most common known genetic risk factor for Parkinson's disease (PD) and are distributed worldwide. Access to *GBA1* genotyping varies across the world and even regionally within countries. Guidelines for *GBA1* variant counseling are evolving. We review the current knowledge of the link between *GBA1* and PD, and discuss the practicalities of *GBA1* testing. Lastly, we provide a consensus for an approach to counseling people with *GBA1* variants, notably the communication of PD risk. © 2024 The Author(s). *Movement Disorders* published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Identifier (DOI)
10.1002/mds.30006
Tags
  • Review

Meet the Authors

Aligning Science Across Parkinson's
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.